An innovative cardiovascular start-up, HDAX Therapeutics, is the latest company to win $250,000 in funding following another year of the Ted Rogers Centre for Heart Research’s Entrepreneurship for Cardiovascular Health Opportunities (ECHO) program. The ECHO program...
Several members of the Ted Rogers Centre for Heart Research (TRCHR) participated in Vascular 2023, a five-day conference held in Montreal from October 25-29. The conference is a hallmark event organized by several Canadian specialist and research organizations,...
Researchers at the Ted Rogers Centre for Heart Research have developed an innovative approach to better understanding the complex signaling mechanisms underlying heart failure. A recent publication in the Proceedings of the National Academy of Sciences (PNAS) offers...
The Rogers Foundation announces a second landmark gift, building on its $130 million gift in 2014, to sustain the Ted Rogers Centre for Heart Research in perpetuity and bring the promise of precision cardiac health to patients across Canada and globally. In 2014, the...
Ted Rogers Chair in Heart Function Outcomes Dr. Douglas Lee leads new Heart-Brain Connection $3 million IMPACT Award project
Four unique educational events in October and December
Join us Thursday, October 12, 2023 for ECHO PITCH, a special event where six top cardiovascular health start-ups compete for funding from a $250,000 pool in front of a panel of judges and a live audience.
These six finalists have been selected from the Entrepreneurship for Cardiovascular Health Opportunities (ECHO) program, where they received 12 months of hands-on entrepreneurship training and mentorship.
Day(s)
:
Hour(s)
:
Minute(s)
:
Second(s)
Join us to learn, network, and set your entrepreneurial spirit free! Space is limited, so register early to reserve your spot!
ECHO is a specialized training program led by veteran entrepreneurs and consultants across a variety of sectors. Its mission:
ECHO is funded and organized by the Translational Biology and Engineering Program, at the University of Toronto and the Ted Rogers Centre for Heart Research, in partnership with the Health Innovation Hub (H2i).